This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 730357 Are Taken up in the Body and How Well They Are Tolerated

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 21, 2019

Primary Completion Date

April 26, 2019

Study Completion Date

April 26, 2019

Conditions
Healthy
Interventions
DRUG

BI 730357

single rising oral dose

DRUG

Placebo

single rising oral dose

Trial Locations (1)

130-0004

SOUSEIKAI Sumida Hospital, Tokyo, Sumida-ku

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY